But just how safe are COVID-19 vaccines, really? Dr. Joel Gelfand offers us the answer, and it's a relief. Listen in for practical tips for patients on biologics and with other existing skin conditions. Each Thursday, join Dr. Raja and Dr. Hadar, board-certified dermatologists, as they share the latest evidence-based research in integrative dermatology. For access to CE/CME courses, become a member at LearnSkin.com.   Dr. Joel M. Gelfand is Assistant Professor of Dermatology and Epidemiology, Senior Scholar, Center for Clinical Epidemiology and Biostatistics, Associate Fellow, Center for Public Health Initiatives, Medical Director of the Clinical Studies Unit in the Department of Dermatology, and a Member of the Cancer Center and Institute for Translational Medicine and Therapeutics, all at the University of Pennsylvania. Additionally, he is the principal investigator for the Dermatology Clinical Effectiveness Research Network (DCERN), a multi-center study evaluating the effectiveness of treatments for moderate to severe psoriasis, founded by an RC1 grant from NIAMS. He is a board-certified dermatologist whose clinical work focuses on general dermatology and psoriasis.